First Allied Advisory Services Inc. increased its position in Colgate-Palmolive (NYSE:CL) by 4.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 68,127 shares of the company’s stock after purchasing an additional 3,129 shares during the quarter. First Allied Advisory Services Inc.’s holdings in Colgate-Palmolive were worth $4,958,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in CL. Alyeska Investment Group L.P. lifted its holdings in Colgate-Palmolive by 33.5% during the third quarter. Alyeska Investment Group L.P. now owns 1,670,188 shares of the company’s stock worth $121,673,000 after buying an additional 419,239 shares during the period. Taurus Asset Management LLC lifted its holdings in Colgate-Palmolive by 1.6% during the third quarter. Taurus Asset Management LLC now owns 184,210 shares of the company’s stock worth $13,420,000 after buying an additional 2,915 shares during the period. First Republic Investment Management Inc. lifted its holdings in shares of Colgate-Palmolive by 2.3% during the 3rd quarter. First Republic Investment Management Inc. now owns 372,750 shares of the company’s stock valued at $27,155,000 after purchasing an additional 8,274 shares during the last quarter. Prospector Partners LLC lifted its holdings in shares of Colgate-Palmolive by 82.7% during the 3rd quarter. Prospector Partners LLC now owns 138,250 shares of the company’s stock valued at $10,072,000 after purchasing an additional 62,600 shares during the last quarter. Finally, Segall Bryant & Hamill LLC lifted its holdings in shares of Colgate-Palmolive by 12.9% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 16,336 shares of the company’s stock valued at $1,190,000 after purchasing an additional 1,862 shares during the last quarter. 72.86% of the stock is currently owned by institutional investors.

In other Colgate-Palmolive news, insider Jennifer Daniels sold 7,375 shares of the stock in a transaction dated Wednesday, December 13th. The stock was sold at an average price of $73.18, for a total transaction of $539,702.50. Following the sale, the insider now directly owns 38,691 shares of the company’s stock, valued at approximately $2,831,407.38. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CMO Mukul Deoras sold 7,500 shares of the stock in a transaction dated Friday, November 10th. The stock was sold at an average price of $73.28, for a total value of $549,600.00. Following the sale, the chief marketing officer now directly owns 45,217 shares in the company, valued at $3,313,501.76. The disclosure for this sale can be found here. Insiders have sold a total of 181,950 shares of company stock worth $13,237,385 over the last ninety days. 1.02% of the stock is owned by insiders.

Colgate-Palmolive (NYSE CL) opened at $76.63 on Friday. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. Colgate-Palmolive has a 12-month low of $63.43 and a 12-month high of $77.29. The stock has a market capitalization of $67,333.11, a price-to-earnings ratio of 29.59, a P/E/G ratio of 3.20 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the consensus estimate of $0.73. The company had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The firm’s revenue for the quarter was up 2.8% compared to the same quarter last year. During the same period last year, the firm earned $0.73 EPS. research analysts predict that Colgate-Palmolive will post 2.87 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.09%. The ex-dividend date is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio is currently 61.78%.

CL has been the subject of several analyst reports. Morgan Stanley upgraded Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $75.00 to $84.00 in a report on Monday, September 25th. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price objective for the company in a report on Monday, September 25th. Jefferies Group reiterated a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a report on Thursday, September 28th. Royal Bank of Canada reiterated a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a report on Sunday, October 8th. Finally, SunTrust Banks upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and increased their price objective for the company from $65.00 to $85.00 in a report on Wednesday, October 11th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $76.45.

TRADEMARK VIOLATION NOTICE: “Colgate-Palmolive (CL) Shares Bought by First Allied Advisory Services Inc.” was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at https://theolympiareport.com/2018/01/19/colgate-palmolive-cl-shares-bought-by-first-allied-advisory-services-inc.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.